The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term OS for patients with advanced NSCLC enrolled in the KEYNOTE-001 study of pembrolizumab (pembro).
 
Rina Hui
Honoraria - AstraZeneca; Boehringer Ingelheim; Merck Sharp & Dohme
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Pfizer
 
Leena Gandhi
Honoraria - Merck
Consulting or Advisory Role - Merck; Roche/Genentech
Research Funding - Bristol-Myers Squibb
 
Enric Carcereny Costa
No Relationships to Disclose
 
Enriqueta Felip
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Speakers' Bureau - Bristol-Myers Squibb; Novartis; Roche
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
Research Funding - AstraZeneca
 
Joseph Paul Eder
Honoraria - Merck
 
Ani Sarkis Balmanoukian
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst)
 
Natasha B. Leighl
Research Funding - Novartis (Inst)
 
Charu Aggarwal
Consulting or Advisory Role - Celgene (I); Genentech; Genentech (I)
Speakers' Bureau - Genentech (I); Novartis (I); Pfizer (I)
Research Funding - Genentech/Roche; Millennium; Nektar
 
Leora Horn
Honoraria - Biodesix
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Merck; Puma Biotechnology; Xcovery
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst)
 
Amita Patnaik
Consulting or Advisory Role - Bayer
Research Funding - AVEO (Inst); Bayer (Inst); Corvus Pharmaceuticals (Inst); Jiangsu Hengrui Medicine (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Plexxikon (Inst); Symphony Evolution (Inst); Tesaro (Inst)
 
Gary William Middleton
Stock and Other Ownership Interests - Agenus
Honoraria - Lilly; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Pierre Fabre
Research Funding - AstraZeneca; Kael-Gemvax
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Matthew A. Gubens
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Clovis Oncology; Nektar; Pfizer
Research Funding - Abbvie (Inst); Celgene (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); OncoMed (Inst)
Travel, Accommodations, Expenses - Celgene; Genentech/Roche
 
Matthew David Hellmann
Consulting or Advisory Role - Third Rock Ventures
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech
 
Jean-Charles Soria
Honoraria - AstraZeneca/MedImmune; Merus; MSD Oncology; Pfizer; Roche/Genentech; Symphony Evolution
 
Suresh S. Ramalingam
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly/ImClone; Merck; Novartis
Travel, Accommodations, Expenses - AstraZeneca; EMD Serono; Pfizer
 
Gregory M. Lubiniecki
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Jin Zhang
Employment - Merck
 
Bilal Piperdi
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Edward B. Garon
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)